Teva and Takeda enter into new venture for generics in Japan
Executive Summary
Teva Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Co. Ltd. entered into a new partnership in Japan. The new venture will begin in Q2 2016 with Teva owning 51% and Takeda 49%. The partnership will operate as an independent company with its own board and management team. Further details have not yet been disclosed.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- OTC, Consumer
Deal Status
- Final
Deal Type
-
Alliance
- Joint Venture
- Marketing (Licensing)
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice